Coloplast divests core Skin Care product portfolio

GlobeNewswire12-04

The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area. Revenue from the core Skin Care business amounted ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2488634162?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vtOyV58KsIYMzqeBgs6Kag--~B/aD0xMTgyO3c9MjQ3MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/133f9853fa5e77f27e2587159807b598","is_english":true,"pubTime":"2024-12-04 20:01","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2488634162","market":"us","top_or_hot":-1,"title":"Coloplast divests core Skin Care product portfolio","media":"GlobeNewswire","content":"<div>\n<p>The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area.\nRevenue from the core Skin Care business amounted ...</p>\n\n<a href=\"https://finance.yahoo.com/news/coloplast-divests-core-skin-care-120100625.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coloplast divests core Skin Care product portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColoplast divests core Skin Care product portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-04 20:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/coloplast-divests-core-skin-care-120100625.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area.\nRevenue from the core Skin Care business amounted ...</p>\n\n<a href=\"https://finance.yahoo.com/news/coloplast-divests-core-skin-care-120100625.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://finance.yahoo.com/news/coloplast-divests-core-skin-care-120100625.html","article_id":"2488634162","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vtOyV58KsIYMzqeBgs6Kag--~B/aD0xMTgyO3c9MjQ3MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/133f9853fa5e77f27e2587159807b598"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488634162","pubTimestamp":1733313660,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area.Revenue from the core Skin Care business amounted to around DKK 400 million in FY 2023/24, with an operating profitability level significantly below the group EBIT margin.Coloplast’s FY 2024/25 financial guidance1 of organic revenue growth at 8-9% and an EBIT margin before special items of around 28% is unchanged and already includes the divestment. This simplification of the portfolio will benefit the operating profitability of Advanced Wound Care and accounts for the majority of the around 30 basis points positive impact on the group EBIT margin as highlighted in the FY 2023/24 earnings release1.The divestment will reduce reported revenue for FY 2024/25 with around DKK 350 million, or around -1.5%-points impact on reported revenue growth.One-off items related to the divestment are included in the FY 2024/25 special items expectations of D","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","CLPBY":"Coloplast AS","CLPBF":"Coloplast AS"},"translate_title":"康乐保剥离核心护肤品组合","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLPBF":0.9,"CLPBY":0.9},"content_text":"The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area.\nRevenue from the core Skin Care business amounted to around DKK 400 million in FY 2023/24, with an operating profitability level significantly below the group EBIT margin.\nColoplast’s FY 2024/25 financial guidance1 of organic revenue growth at 8-9% and an EBIT margin before special items of around 28% is unchanged and already includes the divestment. This simplification of the portfolio will benefit the operating profitability of Advanced Wound Care and accounts for the majority of the around 30 basis points positive impact on the group EBIT margin as highlighted in the FY 2023/24 earnings release1.\nThe divestment will reduce reported revenue for FY 2024/25 with around DKK 350 million, or around -1.5%-points impact on reported revenue growth.\nOne-off items related to the divestment are included in the FY 2024/25 special items expectations of DKK 130 million.\nThe transaction has been signed and completed on 3 December 2024. Specific terms of the transaction have not been disclosed.\n1) More information about Coloplast’s FY 2024/25 financial guidance here: FY 2023/24 Earnings release \nContactsInvestors and analysts Anders Lonning-SkovgaardExecutive Vice President, CFOTel. +45 4911 1111\nAleksandra DimovskaVice President, Investor Relations+45 4911 2458dkadim@coloplast.com\nPress and media:Peter MønsterSr. Media Relations Manager+45 4911 2623dkpete@coloplast.com\n Attachment \n\n Coloplast_Skin_care_press_release_EN","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488634162"}